BIO.B
Bio-Rad Laboratories B·NYSE
--
--(--)
--
--(--)
1.00 / 10
Underperform
Technical assessment is weak, with the stock trapped in an overbought RSI zone and a confirmed MACD death cross. Both indicators carry negative historical returns (-0.06% and -1.83%, respectively), and no bullish signals were detected in the last five days. This bearish setup tempers near-term enthusiasm and aligns with an 'Underperform' technical rating.
Analysis Checks(0/2)
RSI Overbought
Score1/10
Win Rate9.30%
Hist. Signals86
Avg Return-0.06%
Score1/10
Win Rate9.30%
Hist. Signals86
Avg Return-0.06%
MACD Death Cross
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-1.83%
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-1.83%
RSI Overbought
Score1/10
Win Rate9.30%
Hist. Signals86
Avg Return-0.06%
Score1/10
Win Rate9.30%
Hist. Signals86
Avg Return-0.06%
MACD Death Cross
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-1.83%
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-1.83%
Technical Analysis of BIO.B?
- BIO.B presents a Underperform setup with a Technical Score of 1.00/10. Key technical indicators highlight an RSI of 7.81 and a MACD of -4.24, with the trend anchored by the 50-Day SMA at 309.50. Traders should monitor key support at 295.05 and resistance at 295.05.
